Trial Profile

Phase 2 Study of NU172 Anticoagulation in Patients Undergoing Coronary Artery Bypass Graft Surgery OFF-Pump.

Status: Not yet recruiting

Phase of Trial: Phase II

Latest Information Update: 09 Nov 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs NU 172 (Primary)
Indications Thrombosis
Focus Adverse reactions; Therapeutic Use
Acronyms SNAP-CABG-OFF
Sponsors ARCA biopharma Inc

Most Recent Events

09 Jun 2011 Planned end date changed from 1 Sep 2010 to 1 Sep 2013 as reported by ClinicalTrials.gov.
09 Jul 2009 Planned end date changed from Mar 2010 to Sep 2010 as reported by ClinicalTrials.gov.
19 Mar 2009 ARCA biopharma added as trial affiliate as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com